2025
SJR Q3
JCR Q4 · 1,3
23 eşleşen makale
SCIE
Dergi ayrıntısı
International Journal of Toxicology
- Yayıncı
- SAGE Publications Inc.
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
109158181092874X
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,397
- Quartile Q3
- H-Index 79
- Atıf/yayın 1,35
- Doküman (3y) 199
- Atıf (3y) 309
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 1,3
- 5Y JIF 2
- JCI 0,3
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Toxicology Q3
Alanlar
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Pharmacology & Pharmacy | Toxicology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,397 | 1,3 | 2 | 0,3 | Q4 | 79 |
| 2024 | Q3 | Q4 | 0,415 | 1 | 1,9 | 0,28 | Q4 | 73 |
| 2023 | Q3 | Q4 | 0,467 | 1,2 | 2,2 | 0,44 | Q3 | 73 |
| 2022 | Q3 | Q3 | 0,432 | 2,2 | 2,3 | 0,48 | Q3 | 73 |
| 2021 | Q3 | Q4 | 0,487 | 2,4 | 2,4 | 0,5 | Q3 | 73 |
| 2020 | Q3 | Q4 | 0,432 | 2 | 1,9 | 0,42 | Q4 | 73 |
| 2019 | Q3 | Q4 | 0,535 | 1,3 | 1,5 | 0,47 | Q3 | 73 |
| 2018 | — | Q4 | — | 1,2 | 1,3 | 0,45 | Q3 | — |
| 2017 | Q3 | Q4 | 0,449 | 1,5 | 1,5 | 0,49 | Q3 | 73 |
| 2016 | Q3 | Q4 | 0,382 | 1,2 | 1,2 | — | — | 73 |
| 2015 | Q3 | Q4 | 0,477 | 1,1 | 1,4 | — | — | 73 |
| 2014 | Q3 | Q4 | 0,442 | 1,3 | 1,4 | — | — | 73 |
| 2013 | Q3 | Q4 | 0,518 | 1,2 | 1,4 | — | — | 73 |
| 2012 | Q3 | Q3 | 0,438 | 1,3 | 1,4 | — | — | 73 |
| 2011 | Q3 | Q3 | 0,415 | 1,3 | 1,5 | — | — | 73 |
| 2010 | Q3 | Q3 | 0,551 | 1,8 | 1,7 | — | — | 73 |
| 2009 | — | Q4 | — | 1,2 | 1,3 | — | — | — |
| 2008 | — | Q4 | — | 1,3 | 1,3 | — | — | — |
| 2007 | — | Q4 | — | 1,1 | 1,3 | — | — | — |
| 2006 | — | Q4 | — | 1,1 | — | — | — | — |
| 2005 | — | Q3 | — | 1 | — | — | — | — |
| 2004 | — | Q4 | — | 0,9 | — | — | — | — |
| 2003 | — | Q4 | — | 0,7 | — | — | — | — |
| 2002 | — | Q4 | — | 0,5 | — | — | — | — |
| 2001 | — | Q4 | — | 0,2 | — | — | — | — |
| 2000 | — | Q4 | — | 0,4 | — | — | — | — |
| 1999 | — | Q4 | — | 0,4 | — | — | — | — |
| 1998 | — | Q4 | — | 0,2 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 299/356 |
| 2025 | TOXICOLOGY | SCIE | Q4 | Q4 | 100/106 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 305/352 |
| 2024 | TOXICOLOGY | SCIE | Q4 | Q4 | 100/106 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 290/354 |
| 2023 | TOXICOLOGY | SCIE | Q4 | Q4 | 98/106 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 208/278 |
| 2022 | TOXICOLOGY | SCIE | Q4 | Q4 | 74/94 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 214/279 |
| 2021 | TOXICOLOGY | SCIE | Q4 | Q4 | 79/94 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q4 | 221/276 |
| 2020 | TOXICOLOGY | SCIE | Q4 | Q4 | 82/93 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 242/271 |
| 2019 | TOXICOLOGY | SCIE | Q4 | Q4 | 88/92 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 231/267 |
| 2018 | TOXICOLOGY | SCIE | Q4 | Q4 | 88/93 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 211/261 |
| 2017 | TOXICOLOGY | SCIE | Q4 | Q4 | 79/94 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 214/257 |
| 2016 | TOXICOLOGY | SCIE | Q4 | — | 86/92 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 219/255 |
| 2015 | TOXICOLOGY | SCIE | Q4 | — | 81/90 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 192/255 |
| 2014 | TOXICOLOGY | SCIE | Q4 | — | 70/88 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 193/256 |
| 2013 | TOXICOLOGY | SCIE | Q4 | — | 69/87 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 187/261 |
| 2012 | TOXICOLOGY | SCIE | Q4 | — | 69/85 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 194/261 |
| 2011 | TOXICOLOGY | SCIE | Q4 | — | 66/83 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 156/252 |
| 2010 | TOXICOLOGY | SCIE | Q3 | — | 57/83 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 182/237 |
| 2009 | TOXICOLOGY | SCIE | Q4 | — | 61/77 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 167/219 |
| 2008 | TOXICOLOGY | SCIE | Q4 | — | 59/75 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 161/205 |
| 2007 | TOXICOLOGY | SCIE | Q4 | — | 59/73 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 152/199 |
| 2006 | TOXICOLOGY | SCIE | Q4 | — | 61/76 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 152/193 |
| 2005 | TOXICOLOGY | SCIE | Q3 | — | 56/75 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 146/187 |
| 2004 | TOXICOLOGY | SCIE | Q4 | — | 57/75 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 149/185 |
| 2003 | TOXICOLOGY | SCIE | Q4 | — | 61/77 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 166/188 |
| 2002 | TOXICOLOGY | SCIE | Q4 | — | 71/76 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 180/186 |
| 2001 | TOXICOLOGY | SCIE | Q4 | — | 77/78 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 167/181 |
| 2000 | TOXICOLOGY | SCIE | Q4 | — | 72/77 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 155/175 |
| 1999 | TOXICOLOGY | SCIE | Q4 | — | 67/74 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 171/178 |
| 1998 | TOXICOLOGY | SCIE | Q4 | — | 67/71 |